healthy volunteer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)20 to 34 years at the time of obtaining informed consent (2) BMI>=18.5, <25.0
Exclusion criteria
Exclusion criteria: (1)any medical history of illness and allergy to be conceivable that is unsuitable to enroll for the study (2)any skin abnormality (3)any abnormal findings in standard Labtest or vital signs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of lanoconazole in stratum corneum in each application time points by 24 hours after drug application | — |
Countries
Japan
Contacts
SOUSEIKAI Hakata Clinic Department of Clinical Operations